Chemotherapy and immunotherapy are two commonly used cancer treatments, but they differ in some key ways. One of the main differences is that chemotherapy uses drugs that destroy cells, including both cancer and healthy cells. Immunotherapy doesn’t directly attack cancer cells but instead helps the...
Causing fewer and more mild side effects than chemotherapy Helping your immune system fight cancer even after you’ve stopped treatment Increasing your odds of remission (where all signs of cancer disappear) Shrinking tumors and preventing your cancer from spreading As researchers continue to study the...
The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, ...
Unlike traditional cancer treatments such as radiotherapy and chemotherapy, immunotherapy is an innovative treatment that dynamically modulates the immune system to attack cancer cells in multiple targets and directions [1]. Immunotherapy is mainly used to strengthen the immune system by regulating the imm...
approved to treat certain kinds, including some types of lymphoma, leukemia, breast cancer, and lung cancer. It can be an option if chemotherapy or other cancer treatments haven't worked for you, or if you couldn't handle the effects of other treatments. Immunotherapy could help you live ...
toxic side effects of chemotherapy usually include hair loss, severe nausea and bowel problems, etc. Chemotherapy frequently fails in cancer treatments due to poor pharmacokinetics and wide distribution in vivo, insufficient delivery and multiple drug resistance (MDR) [64]. At present, combination ther...
[138,139,140]. DeNardo found that the increasing anti-tumor immunity mediated by CD8+T cells is mainly due to the depletion of TAM in a mouse model of breast cancer under chemotherapy treatment [141]. Therefore, TAM can be recommended as one of the vital therapeutic targets to increase ...
inducing stimulated T-cell death, which leads to the emergence of autoimmune diseases [24]. Researchers are currently trying to combine several cytokines or combine cytokines with chemotherapy or other immunotherapies to reduce the dose used and thereby avoid the side effects caused by high doses [...
This meta-analysis investigates the association of neoadjuvant chemoimmunotherapy with patient benefits vs neoadjuvant chemotherapy in patients with
Combination with chemotherapy For both NSCLC and SCLC, chemotherapy remains one of the primary first-line treatment methods. It is noteworthy that, during the process of tumor treatment, chemotherapeutic agents exert bidirectional effects on the immune system, causing systemic immune suppression while als...